Recent ArticlesJITC Editorial Board Popular ArticlesJITC Digest Follow JITC on X

Become a Reviewer

The quality of the journal could not be sustained without the efforts of our dedicated reviewers.

Become a Reviewer >

For Authors

Help enrich communication and advance scientific understanding in cancer immunotherapy.

For Authors >

From the Editors

JITC's distinguished Editorial Board highlights featured content from the journal and beyond.

From the Editors >

JITC Collections

Readers have the opportunity to view JITC's special editions and theme-focused collections.

JITC Collections >

An Interview with the Editor-in-Chief Dr. Lotze

In this video interview, Editor-in-Chief Dr. Michael Lotze shares his vision for JITC, what he looks for in submitted research, and the types of content he recommends for clinical and research audiences.

He also offers his perspective on timely topics including climate-related science, content integrity, and the role of AI in publishing.

Watch now to hear directly from the Editor-in-Chief!

JITC Awards

Together with SITC, the journal recognizes key contributors to the journal and field of cancer immunotherapy, both in leadership and in research.

Annual JITC Best Paper Awards celebrate excellence in scientific research and are awarded to researchers demonstrating leadership in the field as well as innovation and high-quality execution and discussion in their manuscripts.

The Pedro J. Romero, MD Service to JITC Award recognizes an individual who has made significant contributions and demonstrated outstanding commitment to the journal.

APC Discounts

As a way to thank the SITC members who work tirelessly to advance the science and improve the lives of cancer patients, SITC members who are first, last, or corresponding authors on JITC articles at the time of acceptance will receive discounted Article Processing Charges (APCs). This discount is applied post-acceptance, at which point a discount code is shared with the corresponding author. 

JITC also offers full waivers for the full APC (100% discount of the APC) where all authors are based in low-income countries (see policy). Requests for waivers must be made prior to submission. 

For additional information regarding these discounts, as well as institutional arrangements and editor/reviewer discounts, view the journal's APC policy. Additional questions may be directed to JITCEditor@sitcancer.org.

Popular Articles

The selections below represent some of the most popular content published in JITC over the past two years. Explore additional thematic content in JITC's Collections or access the rest of JITC's archives for a look at all the journal has to offer.

Endothelial Activation and Stress Index (EASIX) to predict mortality after allogeneic stem cell transplantation: a prospective study (9 January 2024)
RESEARCH

Spatial and single-cell transcriptomics reveal cellular heterogeneity and a novel cancer-promoting Treg cell subset in human clear-cell renal cell carcinoma   (4 January 2025 )
RESEARCH

Tumor mutational burden and survival on immune checkpoint inhibition in >8000 patients across 24 cancer types  (6 February 2025)
RESEARCH

Voxel-level radiomics and deep learning for predicting pathologic complete response in esophageal squamous cell carcinoma after neoadjuvant immunotherapy and chemotherapy 
(15 March 2025)
RESEARCH

Browse the Current Issue

Read More

JITC Collections and Special Issues

Within JITC's full catalog of published articles, a number of collections are available to provide readers with opportunities to view sets of papers following particular themes. 

NEW! Myeloid Cells in Immuno-Oncology

posted 12-02-2025
Edited by Dmitry I. Gabrilovich, MD, PhD; Jennifer Guerriero, PhD; and Judith A. Varner, PhD This JITC series aims to advance the biological understanding of myeloid cell biology within the tumor ...

NEW! SITC 40th Anniversary: I-O Progress and Potential

posted 05-02-2025
In celebration of the 40 th Anniversary of the Society for Immunotherapy of Cancer (SITC), the Journal for ImmunoTherapy of Cancer ( JITC ) presents this special series from luminaries in the field ...

NEW! The Next Wave of Immuno-oncology: A Roadmap from the Society for Immunotherapy of Cancer (SITC)

posted 04-06-2025
The rapid clinical and scientific progress of immuno-oncology (IO) since the approval of the first immune checkpoint inhibitors has changed the spectrum of patient care forever. Recognizing the milestones ...

Computational Immuno-Oncology

posted 02-08-2025
Edited by Alan Hutson, PhD The JITC series “Computational Immuno-Oncology” aims to provide clarity and guidance regarding the discourse on data science technologies and analyses among researchers ...

Cancer Immunotherapy in Understudied Populations

posted 02-06-2025
Edited by Kavita Dhodapkar, MBBS and Johanneke E. A. Portielje, MD, PhD Significant gaps and disparities persist with respect to cancer immunotherapy research across populations and a range of factors, ...

Microbial-Based Cancer Immunotherapy

posted 11-01-2024
Edited by Neil S. Forbes and Grant McFadden While microbial based therapy is one of the oldest cancer therapy modalities, dating from the 1880s, the field is not well-developed. Even after all this ...

Immune Monitoring Technology Primers

posted 10-07-2024
Immune Monitoring Technology Primers 2016 Biomarkers immune monitoring technology primer: Immunoscore® Colon (20 Sept 2016) Immune monitoring technology primer: whole exome sequencing ...

Immune Monitoring Technology Primers

posted 10-01-2024
Immune Monitoring Technology Primers 2016 Biomarkers immune monitoring technology primer: Immunoscore® Colon (20 Sept 2016) Immune monitoring technology primer: whole exome sequencing ...

Cancer Immunotherapy Guidelines

posted 09-01-2024
Cancer Immunotherapy Guidelines Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of nonmelanoma skin cancer (28 July 2022) Society ...

Liquid Biopsies Coming of Age: Biology, Emerging Technologies, and Clinical Translation

posted 05-08-2024
Edited by Valsamo Anagnostou, MD, PhD and Mark D. Stewart, PhD Liquid biopsies have become increasingly utilized approaches in cancer research. As they gain momentum as minimally invasive means for ...